Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mark Adams, Teri Willey, Zunyan Dai, Daniel Sharer, Patricia Hall, More


Good Start Genetics has appointed Mark Adams to Chief Information Officer. Adams joins Good Start from Bridgewater Associates and was previously a principal with Booz Allen Hamilton, where he developed a biomedical informatics consulting practice. He has also been vice president of bioinformatics at Variagenics, and held positions at Incyte. He holds a BA from Oberlin College and a PhD from Baylor College of Medicine.

Cold Spring Harbor Laboratory has appointed Teri Willey to VP of Business Development & Technology Transfer, where she will direct the laboratory's commercialization and technology transfer activities including patenting, licensing, company start-ups, and corporate partnerships and collaborations. She is taking over for John Maroney, who will continue in his role as general counsel.

Willey joins CSHL from Mount Sinai Medical Center, and was also Founding Executive Director of Cambridge Enterprise. She has also served as an advisor to Congress and is a past President of the Association of University Technology Managers.

Emory Genetics Laboratory has hired five new directors that will join full-time within the next month. Zunyan Dai has joined EGL from Quest and will serve as Director, Cytogenetics Laboratory. Daniel Sharer from the University of Alabama at Birmingham and Patricia Hall from the Mayo Clinic will both serve as Director, Biochemical Genetics Laboratory. John Alexander from the University of Alabama at Birmingham; Yuan Xue from the University of California, Los Angeles; and Alice Tanner, a board certified genetic counselor at Emory, will all serve as Director, Molecular Genetics Laboratory.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.